Genetic counseling before Alzheimer's testing is a focused pre-test visit that maps family history, explains test choices and limits, and helps you plan decisions and support. Genetic counseling means guidance from an expert in inherited risk, not the DNA test itself. The visit happens in person or by video with someone who has Alzheimer's-genetics expertise. A symptomatic patient brings a guardian or family member for support and shared decisions.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How will your family history be mapped?
- Which tests might be discussed?
- What can results tell you, and what are the limits?
- How do you plan for family, insurance, and feelings?
How will your family history be mapped?
The counselor builds a pedigree of at least three generations. The National Society of Genetic Counselors via Guideline Central describes this pedigree step in its pre-test counseling guidance. It records diagnoses, ages of onset, current ages or ages at death, and checks records when possible.
That map sorts risk into useful groups, such as early-onset, late-onset, autosomal-dominant, familial, or sporadic. Autosomal-dominant means a pattern that can pass from parent to child in each generation. Familial means more than one relative has disease, while sporadic means no clear family pattern. Bring what you can to make the map accurate:.
- relatives with memory loss or dementia, with diagnosis and age symptoms started
- current ages, or ages at death, for close relatives across three generations
- medical records, death certificates, or prior genetic reports when you have them
Which tests might be discussed?
Testing for PSEN1, PSEN2, and APP looks at deterministic early-onset genes. Deterministic means a harmful change strongly predicts early-onset disease. The NCRAD summary of testing criteria says these tests fit mainly symptomatic early-onset disease, families with an autosomal-dominant early-onset pattern, or known familial mutations in its testing eligibility summary. Testing an affected relative first gives the clearest answer.
Starting with an unaffected relative can return an uninformative negative result. Ask which relative is the best person to test first. APOE testing is different. APOE means susceptibility testing, which only shifts chance for late-onset disease. APOE-e4 raises late-onset risk without being necessary or sufficient, so routine prediction is not clinically recommended and direct-to-consumer APOE testing is specifically not advised.
What can results tell you, and what are the limits?
Counseling explains what testing can and cannot tell. A positive, negative, or uncertain result has a different meaning for you and for blood relatives. An uncertain result may leave risk unclear rather than settle it. A key limit is predictive uncertainty.
An APOE result cannot tell an individual whether disease will develop or when. A negative result in an unaffected person may also be uninformative when the family mutation is unknown. Results guide planning and research choices rather than promise prevention. No proven drug or lifestyle choice currently prevents Alzheimer's or stops progression. Use results to plan care, finances, family talks, and possible research participation.
How do you plan for family, insurance, and feelings?
Expect direct talk about family discussion, consent for cascade testing, and emotional support. Cascade testing means offering testing to at-risk relatives after a family finding. The counselor also reviews insurance and job implications before you consent. U.S.
law adds a concrete boundary. The BrightFocus Foundation explains these protections in its legal considerations resource. The Genetic Information Nondiscrimination Act protects health insurance and employment, but it does not cover life, disability, or long-term-care insurance. Bring a trusted person, list questions about work and coverage, and ask what support is available after disclosure. Decide in advance who may hear your result and how you will share it.
